Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus and Erlotinib in advanced SCCHN
NCT01009203Phase 2Terminated
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Dec 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in squamous cell carcinoma of the head and neck (HNSCC), sponsored by New Mexico Cancer Research Alliance. Started Dec 2009; status: terminated.
02
Drugs
temsirolimus
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01009203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009203.